Literature DB >> 21146612

Purify First: rapid expression and purification of proteins from XMRV.

William K Gillette1, Dominic Esposito, Troy E Taylor, Ralph F Hopkins, Rachel K Bagni, James L Hartley.   

Abstract

Purifying proteins from recombinant sources is often difficult, time-consuming, and costly. We have recently instituted a series of improvements in our protein purification pipeline that allows much more accurate choice of expression host and conditions and purification protocols. The key elements are parallel cloning, small scale parallel expression and lysate preparation, and small scale parallel protein purification. Compared to analyzing expression data only, results from multiple small scale protein purifications predict success at scale-up with greatly improved reliability. Using these new procedures we purified eight of nine proteins from xenotropic murine leukemia virus-related virus (XMRV) on the first attempt at large scale.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146612     DOI: 10.1016/j.pep.2010.12.003

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  16 in total

1.  Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease.

Authors:  Mi Li; Alla Gustchina; Krisztina Matúz; Jozsef Tözsér; Sirilak Namwong; Nathan E Goldfarb; Ben M Dunn; Alexander Wlodawer
Journal:  FEBS J       Date:  2011-10-10       Impact factor: 5.542

2.  Crystal structures of the reverse transcriptase-associated ribonuclease H domain of xenotropic murine leukemia-virus related virus.

Authors:  Dongwen Zhou; Suhman Chung; Maria Miller; Stuart F J Le Grice; Alexander Wlodawer
Journal:  J Struct Biol       Date:  2012-02-16       Impact factor: 2.867

3.  Inhibition of XMRV and HIV-1 proteases by pepstatin A and acetyl-pepstatin.

Authors:  Krisztina Matúz; János Mótyán; Mi Li; Alexander Wlodawer; József Tőzsér
Journal:  FEBS J       Date:  2012-08-17       Impact factor: 5.542

4.  Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase.

Authors:  Verónica Barrioluengo; Yi Wang; Stuart F J Le Grice; Luis Menéndez-Arias
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

5.  Polycistronic baculovirus expression of SUGT1 enables high-yield production of recombinant leucine-rich repeat proteins and protein complexes.

Authors:  Kelly Snead; Vanessa Wall; Hannah Ambrose; Dominic Esposito; Matthew Drew
Journal:  Protein Expr Purif       Date:  2022-02-04       Impact factor: 1.650

6.  Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.

Authors:  Stig M R Jensen; Francis W Ruscetti; Alan Rein; Daniel C Bertolette; Carrie J Saucedo; Barry R O'Keefe; Kathryn S Jones
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

7.  Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

Authors:  M F Kearney; K Lee; R K Bagni; A Wiegand; J Spindler; F Maldarelli; P A Pinto; W M Linehan; C D Vocke; K A Delviks-Frankenberry; R W Devere White; G Q Del Prete; J W Mellors; J D Lifson; V N Kewalramani; V K Pathak; J M Coffin; S F J Le Grice
Journal:  Adv Virol       Date:  2011-11-17

8.  Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer.

Authors:  Jonas Blomberg; Ali Sheikholvaezin; Amal Elfaitouri; Fredrik Blomberg; Anna Sjösten; Johan Mattson Ulfstedt; Rüdiger Pipkorn; Clas Källander; Christina Ohrmalm; Göran Sperber
Journal:  Adv Virol       Date:  2011-09-04

9.  An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.

Authors:  Louis M Schwartzman; Andrea L Cathcart; Lindsey M Pujanauski; Li Qi; John C Kash; Jeffery K Taubenberger
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

10.  Ubinuclein-1 confers histone H3.3-specific-binding by the HIRA histone chaperone complex.

Authors:  M Daniel Ricketts; Brian Frederick; Henry Hoff; Yong Tang; David C Schultz; Taranjit Singh Rai; Maria Grazia Vizioli; Peter D Adams; Ronen Marmorstein
Journal:  Nat Commun       Date:  2015-07-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.